CoChat

A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis

Open access
Imai, Shin-ichiro · 2010 · Pharmacological Research
Cited by 89

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Aging science has recently drawn much attention, and discussions on the possibility of anti-aging medicine have multiplied. One potential target for the development of anti-aging drugs is the SIR2 (silent information regulator 2) family of NAD-dependent deacetylases/ADP-ribosyltransferases, called “sirtuins.” Sirtuins regulate many fundamental biological processes in response to a variety of environmental and nutritional stimuli. In mammals, the mammalian SIR2 ortholog SIRT1 has been most studied, and small molecule SIRT1 activators (STACs), including a plant-derived polyphenolic compound resveratrol, have been developed. On the other hand, sirtuin activity is regulated by NAD biosynthetic pathways, and nicotinamide phosphoribosyltransferase (NAMPT) plays a critical role in the regulation of mammalian sirtuin activity. Recent studies have provided a proof of concept for the idea that nicotinamide mononucleotide (NMN), the NAMPT reaction product, can be used a nutriceutical to activate SIRT1 activity. Based on these recent findings, the possibility of sirtuin-targeted nutriceutical development will be discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2010.01.006

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 51

  1. Stagnitti MN. Trends in statins utilization and expenditures for the U.S. Civilian noninstitutionalized population, 2000 and 2005. In: Quality AfHRa (Ed.), 2008.
  2. Blagosklonny, 2007, An anti-aging drug today: from senescence-promoting genes to anti-aging pill, Drug Discov Today, 12, 218, 10.1016/j.drudis.2007.01.004 · DOI
  3. Wick, 2002, ‘Anti-aging’ medicine: does it exist? A critical discussion of ‘anti-aging health products’, Exp Gerontol, 37, 1137, 10.1016/S0531-5565(02)00081-5 · DOI
  4. Ho, 2009, Anti-aging herbal medicine-how and why can they be used in aging-associated neurodegenerative diseases?, Ageing Res Rev
  5. Imai, 2000, Transcriptional silencing and longevity protein SIR2 is an nad-dependent histone deacetylase, Nature, 403, 795, 10.1038/35001622 · DOI · Paper page
  6. Blander, 2004, The Sir2 family of protein deacetylases, Annu Rev Biochem, 73, 417, 10.1146/annurev.biochem.73.011303.073651 · DOI · Paper page
  7. Astrom, 2003, The drosophila melanogaster sir2+ gene is nonessential and has only minor effects on position-effect variegation, Genetics, 163, 931, 10.1093/genetics/163.3.931 · DOI · Paper page
  8. Howitz, 2003, Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 · DOI · Paper page
  9. Tissenbaum, 2001, Increased dosage of a sir-2 gene extends lifespan in caenorhabditis elegans, Nature, 410, 227, 10.1038/35065638 · DOI · Paper page
  10. Wang, 2006, Overlapping and distinct functions for a caenorhabditis elegans sir2 and daf-16/foxo, Mech Ageing Dev, 127, 48, 10.1016/j.mad.2005.09.005 · DOI · Paper page
  11. Imai, 2009, The NAD World: a new systemic regulatory network for metabolism and aging - Sirt1, systemic NAD biosynthesis, and their importance, Cell Biochem Biophys, 53, 65, 10.1007/s12013-008-9041-4 · DOI · Paper page
  12. Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem J, 404, 1, 10.1042/BJ20070140 · DOI · Paper page
  13. Schwer, 2008, Conserved metabolic regulatory functions of sirtuins, Cell Metab, 7, 104, 10.1016/j.cmet.2007.11.006 · DOI · Paper page
  14. Imai, 2009, Therapeutic potential of sirt1 and nampt-mediated nad biosynthesis in type 2 diabetes, Front Biosci, 14, 2983, 10.2741/3428 · DOI · Paper page
  15. Milne, 2008, The sirtuin family: therapeutic targets to treat diseases of aging, Curr Opin Chem Biol, 12, 11, 10.1016/j.cbpa.2008.01.019 · DOI · Paper page
  16. Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354 · DOI · Paper page
  17. Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating Sirt1 and Pgc-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013 · DOI · Paper page
  18. Pearson, 2008, Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span, Cell Metab, 8, 157, 10.1016/j.cmet.2008.06.011 · DOI · Paper page
  19. Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060 · DOI · Paper page
  20. Smith, 2009, Small molecule activators of sirt1 replicate signaling pathways triggered by calorie restriction in vivo, BMC Syst Biol, 3, 31, 10.1186/1752-0509-3-31 · DOI · Paper page
  21. Yamazaki, 2009, Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in msg mice, Am J Physiol Endocrinol Metab, 10.1152/ajpendo.90997.2008 · DOI · Paper page
  22. Westphal, 2007, A therapeutic role for sirtuins in diseases of aging?, Trends Biochem Sci, 32, 555, 10.1016/j.tibs.2007.09.008 · DOI · Paper page
  23. Holub, 2004, Omega-3 fatty acids from fish oils and cardiovascular disease, Mol Cell Biochem, 263, 217, 10.1023/B:MCBI.0000041863.11248.8d · DOI · Paper page
  24. Martin, 2008, Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development, Cardiovasc Hematol Disord Drug Targets, 8, 297, 10.2174/187152908786786214 · doi:10.2174/187152908786786214
  25. Denu, 2003, Linking chromatin function with metabolic networks: Sir2 family of nad(+)-dependent deacetylases, Trends Biochem Sci, 28, 41, 10.1016/S0968-0004(02)00005-1 · DOI · Paper page
  26. Lin, 2003, Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease, Curr Opin Cell Biol, 15, 241, 10.1016/S0955-0674(03)00006-1 · DOI · Paper page
  27. Anderson, 2002, Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state nad+ levels, J Biol Chem, 277, 18881, 10.1074/jbc.M111773200 · DOI · Paper page
  28. Sandmeier, 2002, Telomeric and rdna silencing in saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway, Genetics, 160, 877, 10.1093/genetics/160.3.877 · DOI · Paper page
  29. Yang, 2006, Nampt/pbef/visfatin: a regulator of mammalian health and longevity?, Exp Gerontol, 41, 718, 10.1016/j.exger.2006.06.003 · DOI
  30. Magni, 1999, Enzymology of NAD+ synthesis, Adv Enzymol Relat Areas Mol Biol, 73, 135
  31. Rongvaux, 2003, Reconstructing eukaryotic nad metabolism, Bioessays, 25, 683, 10.1002/bies.10297 · DOI · Paper page
  32. Garten, 2009, Nampt: linking nad biology, metabolism and cancer, Trends Endocrinol Metab, 20, 130, 10.1016/j.tem.2008.10.004 · DOI · Paper page
  33. Imai, 2009, Nicotinamide phosphoribosyltransferase (Nampt): a link between nad biology, metabolism, and diseases, Curr Pharm Des, 15, 20, 10.2174/138161209787185814 · DOI · Paper page
  34. Lau, 2009, The NMN/NaMN adenylyltransferase (nmnat) protein family, Front Biosci, 14, 410, 10.2741/3252 · DOI · Paper page
  35. Preiss, 1957, Enzymatic synthesis of nicotinamide mononucleotide, J Biol Chem, 225, 759, 10.1016/S0021-9258(18)64875-6 · DOI · Paper page
  36. Martin, 2001, Identification of a plasmid-encoded gene from haemophilus ducreyi which confers nad independence, J Bacteriol, 183, 1168, 10.1128/JB.183.4.1168-1174.2001 · DOI · Paper page
  37. Miller, 2003, Complete genome sequence of the broad-host-range vibriophage kvp40: comparative genomics of a t4-related bacteriophage, J Bacteriol, 185, 5220, 10.1128/JB.185.17.5220-5233.2003 · DOI · Paper page
  38. Garten, 2009, Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes, Biochem Biophys Res Commun
  39. Zhang, 2009, Enzymes in the NAD+ salvage pathway regulate sirt1 activity at target gene promoters, J Biol Chem, 284, 20408, 10.1074/jbc.M109.016469 · DOI · Paper page
  40. van der Veer, 2005, Pre-b-cell colony-enhancing factor regulates nad+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation, Circ Res, 97, 25, 10.1161/01.RES.0000173298.38808.27 · DOI · Paper page
  41. van der Veer, 2007, Extension of human cell lifespan by nicotinamide phosphoribosyltransferase, J Biol Chem, 282, 10841, 10.1074/jbc.C700018200 · DOI · Paper page
  42. Ho, 2009, Sirt1 markedly extends replicative lifespan if nad(+) salvage is enhanced, FEBS Lett, 10.1016/j.febslet.2009.08.031 · DOI · Paper page
  43. Fulco, 2008, Glucose restriction inhibits skeletal myoblast differentiation by activating Sirt1 through ampk-mediated regulation of nampt, Dev Cell, 14, 661, 10.1016/j.devcel.2008.02.004 · DOI · Paper page
  44. Skokowa, 2009, Nampt is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway, Nat Med, 15, 151, 10.1038/nm.1913 · DOI · Paper page
  45. Pillai, 2005, Poly(adp-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity, J Biol Chem, 280, 43121, 10.1074/jbc.M506162200 · DOI · Paper page
  46. Hsu, 2009, Nicotinamide phosphoribosyltransferase regulates cell survival through nad+ synthesis in cardiac myocytes, Circ Res, 105, 481, 10.1161/CIRCRESAHA.109.203703 · DOI · Paper page
  47. Moynihan, 2005, Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice, Cell Metab, 2, 105, 10.1016/j.cmet.2005.07.001 · DOI · Paper page
  48. Broetto-Biazon, 2004, The action of extracellular nad+ on ca2+ efflux, hemodynamics and some metabolic parameters in the isolated perfused rat liver, Eur J Pharmacol, 484, 291, 10.1016/j.ejphar.2003.11.024 · doi:10.1016/j.ejphar.2003.11.024
  49. Iozzo, 1999, Independent influence of age on basal insulin secretion in nondiabetic humans: European group for the study of insulin resistance, J Clin Endocrinol Metab, 84, 863, 10.1210/jcem.84.3.5542 · doi:10.1210/jcem.84.3.5542 · Paper page
  50. Muzumdar, 2004, Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action, Diabetes, 53, 441, 10.2337/diabetes.53.2.441 · DOI · Paper page
  51. Williams, 2007, Pellagra: a clue as to why energy failure causes diseases?, Med Hypotheses, 69, 618, 10.1016/j.mehy.2007.01.029 · DOI

Cited by

See all 89

Metadata

Authors
Imai, S.-I.
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2010-07
Volume
62
Issue
1
Pages
42-47
ISSN
1043-6618 (ISSN-L)
OpenAlex
W2013162028
Cited by
89
References
27
FWCI
2.43
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. https://app.cochat.ai/papers/10.1016/j.phrs.2010.01.006
The paper
Imai, S.-I. (2010). A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacological Research. https://doi.org/10.1016/j.phrs.2010.01.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.